Publications scientifiques sur les diagnostics non invasifs BioPredictive

Études évaluées par les pairs validant les diagnostics sanguins BioPredictive pour les maladies du foie — des cohortes pionnières aux méta-analyses à long terme.

10/435 Résultats pour
“DAA, direct-acting antivirals”

“DAA, direct-acting antivirals” Tout effacer

  1. External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV. Key publication

    Poynard T et al. · JHEP Rep · 2021 Score 100

    …CHC) treated or not with antivirals. ### Methods Pre-included patients were from…

    LCR1 LCR2 HCV

  2. Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis.

    Asselah T et al. · Liver Int · 2018 Score 95

    ### Background & Aims Patients with chronic hepatitis C virus infection and advanced fibrosis…

    FibroTest HCV

  3. Management of the patient with SVR. Review

    Terrault NA et al. · J Hepatol · 2016 Score 90

    In the current era of therapy with direct-acting antiviral (DAAs) drugs…

    FibroTest HCV

  4. Real-world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis.

    Preda CM et al. · Liver Int · 2018 Score 85

    ### Background Direct antiviral agents (DAA) showed very good results in terms of…

    FibroTest HCV

  5. HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.

    Steininger K et al. · J Viral Hepat · 2017 Score 80

    …New direct-acting antiviral agent (DAA) combination therapy has not yet been…

    FibroTest HCV HIV

  6. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Key publication

    AASLD/IDSA HCV Guidance Panel · Hepatology · 2015 Score 75

    ActiTest FibroTest HCV

  7. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

    Terrault NA et al. · Hepatology · 2018 Score 70

    ActiTest FibroTest HBV

  8. External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B. Key publication

    Poynard T et al. · Gastro Hep Adv · 2022 Score 65

    …after adjustment for exposure to antivirals, age, gender, geographical origin, HBe-Ag…

    FibroTest LCR1 LCR2 HBV

  9. Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection Key publication

    · 2014 Score 60

    These are the first guidelines dealing with hepatitis C treatment produced by…

    FibroTest HCV

  10. Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. Key publication

    Munteanu M et al. · Aliment Pharmacol Ther · 2016 Score 55

    ### Background Blood tests of liver injury are less well validated in non…

    ActiTest FibroTest SteatoTest Metabolic

Affichage de la liste complète des résultats. La page est rendue côté serveur et non paginée.